查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146917

Piroxicam康膠囊市場：全球市場預測，2026-2032年

Piroxicam Capsules Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，Piroxicam膠囊市場規模將達到 12.3027 億美元，複合年成長率為 12.18%。

主要市場統計數據
基準年 2025 5.5027億美元
預計年份：2026年 5.9677億美元
預測年份 2032 1,230,270,000 美元
複合年成長率 (%) 12.18%

Piroxicam膠囊：概述

Piroxicam膠囊是一種口服非類固醇消炎劑(NSAID)，用於緩解某些肌肉骨骼疾病和風濕性疾病引起的疼痛和發炎。由於Piroxicam的作用持續時間相對較長，且具有顯著的胃腸道、腎臟、心血管和超敏反應風險，因此其使用通常取決於處方指南、患者選擇和風險管理措施。本執行摘要不提供市場估算或預測，而是從監管、臨床、供應、存取和技術角度概述市場狀況。

安全管治與處方實踐的變化

隨著人們越來越重視非類固醇抗發炎藥物（NSAIDs）的安全性、合適的治療療程以及個人化的風險獲益評估，市場格局正在重塑。臨床醫師在開立處方前，越來越重視患者的年齡、心血管病史、腎功能、消化器官系統風險、是否同時使用抗凝血劑或抗血小板藥物、既往過敏史。區域監管差異也影響附加檔、配藥管理、包裝規格以及Piroxicam與其他抗發炎藥物相比的作用。在醫療保健系統尋求有效疼痛管理並同時減少可避免的藥物相關不利事件的同時，供應的連續性、品質保證和負責任的推廣仍然至關重要。

人工智慧增強了臨床和供應鏈決策能力。

人工智慧可以輔助專家對Piroxicam康膠囊的使用和供應管理進行判斷，但無法取代專家判斷。其潛在應用包括：識別胃腸道、腎臟或心血管併發症高風險患者；驗證藥物交互作用；提高藥物安全監測中訊號檢測的準確性；以及透過分析採購和分發數據，幫助醫療系統預測供不應求。自然語言處理工具可以輔助比較附加檔和審查臨床文檔，而需求和庫存分析則有助於改善分銷計劃。這些應用需要檢驗的資料、透明的效能監控、隱私保護和人工監督，因為有偏見或不完整的記錄可能導致做出危及安全的建議。

區域洞察：監管、准入和臨床實踐

在北美，嚴格的標籤標註、處方控制和非類固醇抗發炎藥物相關風險的記錄通常受到重視；而在拉丁美洲，監管執法、醫療保健服務可及性和採購條件則各不相同。在歐洲，重點在於統一的藥物警戒原則、藥物警戒以及在高風險患者中的謹慎用藥。在中東，儘管一些醫療保健系統擁有先進的醫院功能，但處方集和進口要求因地區而異。在非洲，由於診斷、藥物和專科護理的可近性存在差異，基本藥物的品質保證和供應鏈尤其重要。在亞太地區，監管體系、醫療保健支出、學名藥使用和臨床實踐存在顯著差異，因此需要製定適合區域實際情況的藥物管理和分銷策略。

群體分析：多邊集團之間的一致性和差異

東協成員國在監管成熟度、採購系統和合格處方醫師的取得方面存在差異，因此需要在品管和藥品安全監測方面進行協調。金磚國家擁有龐大且多元化的醫療保健體系，以及各國特有的國內生產能力和藥品政策。歐盟受益於通用的法規結構，同時在報銷機制和處方實踐方面保持著國家差異。七國集團（G7）體系通常強調實證安全監測、成熟的監管流程和數位化醫療基礎設施。海灣合作理事會（GCC）國家通常將集中採購和先進的醫院服務與對進口藥品的嚴重依賴相結合。北約成員國的醫療保健模式多種多樣，但藥品儲備、緊急準備和基本藥物供應的持續性是通用的考量。

國家概況：不同的監管和醫療保健環境

澳洲、加拿大、法國、德國、義大利、西班牙、英國和美國均處於成熟的法規環境，處方指南、禁忌症和藥物安全監測均受到重視。巴西、墨西哥、印度、中國、俄羅斯、日本和韓國則各自擁有獨特的核准途徑、報銷系統、生產生態系統和臨床實務組合。在日本和韓國，結構化的醫療服務體系和上市後監測尤其重要。在中國和印度，必須關注顯著的區域差異和複雜的供應鏈。在巴西和墨西哥，有許多公共和私人取得途徑。在澳洲、加拿大、俄羅斯和歐洲國家，必須仔細考慮各國的處方藥目錄、標籤和配藥法規，而不能僅基於地域歸屬來假設。

經營團隊重點：安全、韌性與負責任的創新。

產業領導者應將病患安全作為營運的核心原則，透過建立清晰的禁忌症管理、合理的用藥教育和完善的不利事件通報系統來實現這一目標。他們還需要加強供應商合格、批次追溯以及活性成分、包裝和成品膠囊的緊急時應對計畫。監管策略應根據各司法管轄區的標籤、註冊和藥物警戒要求進行調整。數位化和人工智慧措施應從明確的應用案例、檢驗的資料集、臨床審查和可審計的管治著手。與醫療保健專業人員和公共衛生利益相關人員夥伴關係，有助於提高循證處方的依從性，同時支持就風險和替代方案進行透明溝通。

調查方法：基於證據的市場評估

本評估以Piroxicam膠囊為產品範圍，從臨床實務、監管、可近性、供應連續性、技術和區域因素等角度來整理研究結果。區域、群體和國家層級的觀察結果均基於非類固醇抗發炎藥物風險管理、藥物監管、藥物安全監測、醫療服務和數位健康管治的既定原則進行整合。該方法區分了已記錄的結構性條件和解釋，避免了未經證實的數字聲明，並將不同司法管轄區之間的差異視為關鍵因素。在做出任何操作決策之前，應根據最新的官方產品資訊、國家處方集、監管公告、採購記錄和同行評審的臨床證據對研究結果進行檢驗。

結論：規範使用有助於永續取得。

目前Piroxicam膠囊的現狀更多地取決於處方品質、患者選擇、法律規範以及圍繞其使用的供應管治，而非產品本身的可及性。由於地區和國家差異，統一的策略並不適用，但人工智慧若能負責任地應用，則可在安全監測、藥物審查和庫存管理方面提供寶貴的機會。那些能夠將嚴格的風險管理、健全的品質系統、本地化的監管執行和透明的臨床教育相結合的領導者，將更有能力支持合理用藥並減少可預防的傷害。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章Piroxicam康膠囊市場：依劑型分類

  • 緩釋製劑
  • 標準發布類型

第8章：Piroxicam膠囊市場：依產品類型分類

  • 品牌
  • 非專利的

第9章：Piroxicam康膠囊市場：依劑量強度分類

  • 10 mg
  • 20 mg

第10章：Piroxicam膠囊市場：依分銷管道分類

  • 醫院藥房
    • 私立醫院
    • 公立醫院
  • 網路藥房
    • 製造商網站
    • 第三方平台
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第11章：Piroxicam康膠囊市場：依最終用戶分類

  • 診所
    • 一般診所
    • 專科診所
  • 居家醫療
    • 護理師協助
    • 自我治療
  • 醫院
    • 私立醫院
    • 公立醫院

第12章：Piroxicam膠囊市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：Piroxicam膠囊市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章Piroxicam膠囊市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Cadila Healthcare Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Guangdong Xinfeng Pharmaceutical
  • Guangdong Zhongsheng Pharmaceutical
  • Lupin Ltd.
  • Mylan NV
  • Nouvasant Group
  • Novartis AG
  • Pfizer Inc.
  • SK Chemical
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

第17章 主要專家

Product Code: MRR-3D150775E49C

The Piroxicam Capsules Market is projected to grow by USD 1,230.27 million at a CAGR of 12.18% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 550.27 million
Estimated Year [2026] USD 596.77 million
Forecast Year [2032] USD 1,230.27 million
CAGR (%) 12.18%

Piroxicam Capsules: Executive Overview

Piroxicam capsules are an oral nonsteroidal anti-inflammatory drug (NSAID) formulation used to relieve pain and inflammation in selected musculoskeletal and rheumatic conditions. Because piroxicam has a relatively long duration of action and clinically important gastrointestinal, renal, cardiovascular, and hypersensitivity risks, its use is generally shaped by prescribing guidance, patient selection, and risk-management practices. This executive summary reviews the market through regulatory, clinical, supply, access, and technology lenses without providing market estimates or forecasts.

Safety Governance and Shifting Prescribing Practices

The landscape is being reshaped by stronger emphasis on NSAID safety, appropriate duration of therapy, and individualized benefit-risk assessment. Clinicians increasingly consider age, cardiovascular history, renal function, gastrointestinal risk, concomitant anticoagulants or antiplatelet medicines, and prior hypersensitivity before prescribing. Regulatory differences across jurisdictions also influence labeling, dispensing controls, pack sizes, and the role of piroxicam relative to alternative anti-inflammatory treatments. Supply continuity, quality assurance, and responsible promotion remain important as health systems seek effective pain management while limiting avoidable medicine-related harm.

Artificial Intelligence Strengthens Clinical and Supply Decisions

Artificial intelligence can support, but not replace, professional judgment in piroxicam capsule use and supply management. Potential applications include identifying patients with elevated gastrointestinal, renal, or cardiovascular risk; reviewing medication combinations; improving pharmacovigilance signal detection; and helping health systems anticipate shortages through analysis of procurement and dispensing data. Natural-language tools may assist with label comparison and clinical-document review, while demand and inventory analytics can improve distribution planning. These applications require validated data, transparent performance monitoring, privacy safeguards, and human oversight because biased or incomplete records could produce unsafe recommendations.

Regional Insights: Regulation, Access, and Clinical Practice

North America generally emphasizes stringent labeling, prescription oversight, and documentation of NSAID-related risks, while Latin America reflects varied regulatory enforcement, healthcare access, and procurement conditions. Europe places strong attention on harmonized medicine safety principles, pharmacovigilance, and cautious use in higher-risk patients. The Middle East combines advanced hospital capacity in some systems with differing formulary and import requirements across jurisdictions. Africa is shaped by uneven access to diagnostics, medicines, and specialist care, making quality assurance and essential-medicine supply practices especially important. Asia-Pacific presents substantial diversity in regulatory systems, health expenditure, generic-drug use, and clinical practice, requiring locally appropriate stewardship and distribution strategies.

Group Insights: Alignment and Divergence Across Multilateral Blocs

ASEAN members differ in regulatory maturity, procurement structures, and access to trained prescribers, creating a need for coordinated quality and pharmacovigilance practices. BRICS economies combine large and diverse healthcare systems with varying domestic manufacturing capabilities and medicine policies. The European Union benefits from shared regulatory frameworks while retaining national differences in reimbursement and prescribing practice. G7 systems typically emphasize evidence-based safety monitoring, mature regulatory processes, and digital health infrastructure. GCC countries often combine centralized procurement and advanced hospital services with substantial reliance on imported medicines. NATO members span multiple healthcare models, but medicine resilience, emergency preparedness, and continuity of essential supply are common considerations.

Country Insights: Distinct Regulatory and Healthcare Contexts

Australia, Canada, France, Germany, Italy, Spain, the United Kingdom, and the United States operate within mature regulatory environments where prescribing guidance, contraindications, and pharmacovigilance are prominent. Brazil, Mexico, India, China, Russia, Japan, and South Korea each combine distinct approval pathways, reimbursement arrangements, manufacturing ecosystems, and clinical practices. Japan and South Korea place strong emphasis on structured healthcare delivery and post-market oversight; China and India require attention to broad regional variation and supply-channel complexity; Brazil and Mexico reflect diverse public and private access routes. Australia, Canada, Russia, and the European countries require careful consideration of national formularies, labeling, and dispensing rules rather than assumptions based solely on regional affiliation.

Priorities for Leaders: Safety, Resilience, and Responsible Innovation

Industry leaders should make patient safety the central operating principle by maintaining clear contraindication controls, appropriate-use education, and robust adverse-event reporting. They should strengthen supplier qualification, batch traceability, and contingency planning for active ingredients, packaging, and finished capsules. Regulatory strategies should be tailored to each jurisdiction's labeling, registration, and pharmacovigilance requirements. Digital and AI initiatives should begin with narrowly defined use cases, validated datasets, clinical review, and auditable governance. Partnerships with healthcare professionals and public-health stakeholders can improve adherence to evidence-based prescribing while supporting transparent communication about risks and alternatives.

Research Methodology: Evidence-Led Market Assessment

The assessment uses the defined product scope of piroxicam capsules and organizes findings across clinical practice, regulation, access, supply continuity, technology, and geography. Regional, group, and country observations are synthesized from established principles of NSAID risk management, medicine regulation, pharmacovigilance, healthcare delivery, and digital-health governance. The approach distinguishes documented structural conditions from interpretation, avoids unsupported numerical claims, and treats differences between jurisdictions as material. Findings should be validated against current official product information, national formularies, regulatory notices, procurement records, and peer-reviewed clinical evidence before operational decisions are made.

Conclusion: Disciplined Use Supports Sustainable Access

The piroxicam capsules landscape is defined less by product availability alone than by the quality of prescribing, patient selection, regulatory oversight, and supply governance surrounding use. Regional and country differences make a uniform strategy unsuitable, while AI offers useful opportunities in safety surveillance, medication review, and inventory management when deployed responsibly. Leaders who combine rigorous risk controls, resilient quality systems, locally informed regulatory execution, and transparent clinical education will be better positioned to support appropriate access and reduce preventable harm.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Piroxicam Capsules Market, by Formulation

  • 7.1. Introduction
  • 7.2. Extended Release
  • 7.3. Standard Release

8. Piroxicam Capsules Market, by Product Type

  • 8.1. Introduction
  • 8.2. Branded
  • 8.3. Generic

9. Piroxicam Capsules Market, by Dosage Strength

  • 9.1. Introduction
  • 9.2. 10 Mg
  • 9.3. 20 Mg

10. Piroxicam Capsules Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacy
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Online Pharmacy
    • 10.3.1. Manufacturer Website
    • 10.3.2. Third Party Platform
  • 10.4. Retail Pharmacy
    • 10.4.1. Chain Pharmacy
    • 10.4.2. Independent Pharmacy

11. Piroxicam Capsules Market, by End User

  • 11.1. Introduction
  • 11.2. Clinics
    • 11.2.1. General Clinic
    • 11.2.2. Specialty Clinic
  • 11.3. Home Care Settings
    • 11.3.1. Nurse Assisted
    • 11.3.2. Self Medication
  • 11.4. Hospitals
    • 11.4.1. Private Hospital
    • 11.4.2. Public Hospital

12. Piroxicam Capsules Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Piroxicam Capsules Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Piroxicam Capsules Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Cadila Healthcare Ltd.
  • 16.2. Cipla Ltd.
  • 16.3. Dr. Reddy's Laboratories Ltd.
  • 16.4. Glenmark Pharmaceuticals Ltd.
  • 16.5. Guangdong Xinfeng Pharmaceutical
  • 16.6. Guangdong Zhongsheng Pharmaceutical
  • 16.7. Lupin Ltd.
  • 16.8. Mylan N.V.
  • 16.9. Nouvasant Group
  • 16.10. Novartis AG
  • 16.11. Pfizer Inc.
  • 16.12. SK Chemical
  • 16.13. Sun Pharmaceutical Industries Ltd.
  • 16.14. Teva Pharmaceutical Industries Ltd.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Piroxicam Capsules Market, Years Considered for the Study
  • FIGURE 2. Global Piroxicam Capsules Market, Research Design
  • FIGURE 3. Global Piroxicam Capsules Market, Research Framework
  • FIGURE 4. Global Piroxicam Capsules Market, Data Triangulation
  • FIGURE 5. Global Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Piroxicam Capsules Market Size, by Formulation, 2025 vs 2032 (%)
  • FIGURE 7. Global Piroxicam Capsules Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Piroxicam Capsules Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Piroxicam Capsules Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Piroxicam Capsules Market Size, by Dosage Strength, 2025 vs 2032 (%)
  • FIGURE 11. Global Piroxicam Capsules Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Piroxicam Capsules Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Piroxicam Capsules Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Piroxicam Capsules Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Piroxicam Capsules Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Piroxicam Capsules Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Piroxicam Capsules Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Piroxicam Capsules Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Piroxicam Capsules Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Piroxicam Capsules Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Piroxicam Capsules Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Piroxicam Capsules Market Segmentation & Coverage
  • TABLE 2. Global Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 4. Global Extended Release Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Extended Release Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Extended Release Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Standard Release Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Standard Release Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Standard Release Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 11. Global Branded Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Branded Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Branded Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Generic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Generic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Generic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 18. Global 10 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 19. Global 10 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 20. Global 10 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 21. Global 20 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global 20 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global 20 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 25. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Manufacturer Website Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Manufacturer Website Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Manufacturer Website Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Third Party Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Third Party Platform Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Third Party Platform Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 53. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global General Clinic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global General Clinic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global General Clinic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Nurse Assisted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Nurse Assisted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Nurse Assisted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Self Medication Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Self Medication Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Self Medication Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Asia-Pacific Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Asia-Pacific Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 83. Asia-Pacific Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 84. Asia-Pacific Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 85. Asia-Pacific Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 86. Asia-Pacific Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 87. Asia-Pacific Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 88. Asia-Pacific Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 89. Asia-Pacific Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 90. Asia-Pacific Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 91. Asia-Pacific Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 92. Asia-Pacific Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 93. North America Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. North America Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 95. North America Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 96. North America Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 97. North America Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 98. North America Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 99. North America Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 100. North America Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 101. North America Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 102. North America Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 103. North America Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 104. North America Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 105. Latin America Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Latin America Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 107. Latin America Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 108. Latin America Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 109. Latin America Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 110. Latin America Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 111. Latin America Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 112. Latin America Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 113. Latin America Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 114. Latin America Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 115. Latin America Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 116. Latin America Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 117. Europe Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. Europe Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 119. Europe Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 120. Europe Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 121. Europe Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 122. Europe Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 123. Europe Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 124. Europe Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 125. Europe Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 126. Europe Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 127. Europe Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 128. Europe Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 129. Middle East Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 130. Middle East Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 131. Middle East Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 132. Middle East Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 133. Middle East Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 134. Middle East Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 135. Middle East Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 136. Middle East Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 137. Middle East Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 138. Middle East Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 139. Middle East Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 140. Middle East Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 141. Africa Piroxicam Capsules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 142. Africa Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 143. Africa Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 144. Africa Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 145. Africa Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 146. Africa Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 147. Africa Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 148. Africa Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 149. Africa Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 150. Africa Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 151. Africa Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 152. Africa Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 153. Global Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 154. ASEAN Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 155. ASEAN Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 156. ASEAN Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 157. ASEAN Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 158. ASEAN Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 159. ASEAN Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 160. ASEAN Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 161. ASEAN Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 162. ASEAN Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 163. ASEAN Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 164. ASEAN Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 165. ASEAN Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 166. GCC Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 167. GCC Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 168. GCC Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 169. GCC Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 170. GCC Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 171. GCC Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 172. GCC Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 173. GCC Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 174. GCC Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 175. GCC Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 176. GCC Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 177. GCC Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 178. European Union Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. European Union Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 180. European Union Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 181. European Union Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 182. European Union Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. European Union Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 184. European Union Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 185. European Union Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 186. European Union Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 187. European Union Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 188. European Union Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 189. European Union Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 190. BRICS Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 191. BRICS Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 192. BRICS Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 193. BRICS Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 194. BRICS Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 195. BRICS Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 196. BRICS Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 197. BRICS Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 198. BRICS Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 199. BRICS Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 200. BRICS Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 201. BRICS Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 202. G7 Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 203. G7 Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 204. G7 Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 205. G7 Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 206. G7 Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 207. G7 Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 208. G7 Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 209. G7 Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 210. G7 Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 211. G7 Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 212. G7 Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 213. G7 Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 214. NATO Piroxicam Capsules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 215. NATO Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 216. NATO Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 217. NATO Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 218. NATO Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 219. NATO Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 220. NATO Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 221. NATO Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 222. NATO Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 223. NATO Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 224. NATO Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 225. NATO Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 226. Global Piroxicam Capsules Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 227. United States Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 228. United States Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 229. United States Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 230. United States Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 231. United States Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 232. United States Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 233. United States Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 234. United States Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 235. United States Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 236. United States Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 237. United States Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 238. United States Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 239. Canada Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 240. Canada Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 241. Canada Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 242. Canada Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 243. Canada Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 244. Canada Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 245. Canada Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 246. Canada Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 247. Canada Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 248. Canada Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 249. Canada Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 250. Canada Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 251. Mexico Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 252. Mexico Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 253. Mexico Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 254. Mexico Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 255. Mexico Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 256. Mexico Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 257. Mexico Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 258. Mexico Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 259. Mexico Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 260. Mexico Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 261. Mexico Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 262. Mexico Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 263. Brazil Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 264. Brazil Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 265. Brazil Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 266. Brazil Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 267. Brazil Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 268. Brazil Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 269. Brazil Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 270. Brazil Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 271. Brazil Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. Brazil Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 273. Brazil Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 274. Brazil Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 275. United Kingdom Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 276. United Kingdom Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 277. United Kingdom Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 278. United Kingdom Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 279. United Kingdom Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 280. United Kingdom Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 281. United Kingdom Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 282. United Kingdom Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 283. United Kingdom Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 284. United Kingdom Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 285. United Kingdom Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 286. United Kingdom Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 287. Germany Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 288. Germany Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 289. Germany Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 290. Germany Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 291. Germany Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 292. Germany Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 293. Germany Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 294. Germany Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 295. Germany Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 296. Germany Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 297. Germany Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 298. Germany Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 299. France Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 300. France Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 301. France Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 302. France Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 303. France Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 304. France Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 305. France Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 306. France Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 307. France Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 308. France Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 309. France Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 310. France Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 311. Russia Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 312. Russia Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 313. Russia Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 314. Russia Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 315. Russia Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 316. Russia Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 317. Russia Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 318. Russia Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 319. Russia Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 320. Russia Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 321. Russia Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 322. Russia Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 323. Italy Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 324. Italy Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 325. Italy Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 326. Italy Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 327. Italy Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 328. Italy Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 329. Italy Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 330. Italy Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 331. Italy Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 332. Italy Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 333. Italy Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 334. Italy Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 335. Spain Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 336. Spain Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 337. Spain Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 338. Spain Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 339. Spain Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 340. Spain Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 341. Spain Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 342. Spain Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 343. Spain Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 344. Spain Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 345. Spain Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 346. Spain Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 347. China Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 348. China Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 349. China Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 350. China Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 351. China Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 352. China Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 353. China Piroxicam Capsules Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 354. China Piroxicam Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 355. China Piroxicam Capsules Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 356. China Piroxicam Capsules Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 357. China Piroxicam Capsules Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 358. China Piroxicam Capsules Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 359. India Piroxicam Capsules Market Size, 2017-2032 (USD Million)
  • TABLE 360. India Piroxicam Capsules Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 361. India Piroxicam Capsules Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 362. India Piroxicam Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 363. India Piroxicam Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 364. India Piroxicam Capsules Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 365. India Piroxicam Capsules Marke